ï¼±ï¼ï¼¡ï¼´ï¼¬ãHTLVï¼ï¼© ã¨ã¯ï¼ Aï¼ï¼¡ï¼´ï¼¬ã¯æ人T細èç½è¡ç (Adult T cell Leukemia)ã®ç¥ç§°ã§ãç½è¡ç ã ãã§ãªãããªã³ãè «(Lymphoma)ã®å½¢ãã¨ããã¨ãããããï¼ï¼¡ï¼´ï¼¬ï¼¬ï¼æ人T細èç½è¡ç ã»ãªã³ãè «ï¼ã¨å¼ã¶ãã¨ãããã¾ããHTLVï¼ï¼© (human T-cell leukemia virus type I)ã¯ï¼¡ï¼´ï¼¬ããããã¦ã¤ã«ã¹ã®ååã§ããHTLVï¼ï¼© ã¯ä»ã«ï¼¨ï¼¡ï¼ï¼HTLV-Ié¢é£èé«çï¼çã®ï¼¨ï¼´ï¼¬ï¼¶ï¼ï¼© é¢é£ç¾æ£ãå¼ãããããã¨ãããã¾ãããã ããATLãHAï¼ãçºçããã®ã¯ææè ã®ããä¸é¨ã§ãããã¾ãããã«çºçããããã§ãããã¾ããã ï¼±ï¼ï¼¨ï¼´ï¼¬ï¼¶ï¼ï¼© ã®ææçµè·¯ã¯ï¼ Aï¼ï¼¨ï¼´ï¼¬ï¼¶ï¼ï¼© ã®ä¸»ãªææçµè·¯ã¯ã主ã«æ¯è¦ªããåä¾ã¸ã®æ¯ä¹³ãä»ããæ¯åææã§ãããã®ä»æ§è¡çºã«ããç·æ§ãã女æ§ã¸ã®ææããããã¨ãç¥ããã¦ãã¾ãããã¹ãå¾æ¶²ã§ãã¤ããã¨ã¯ãã¾ãããã¾ãã
åç ãã¥ã¼ã¹ã»ãã©ã¼ã«ã¹ãã®çã¿ãæ¬å½ã«äºåè©ï¼ããèæ³³ããã¹ããã§ç¢ºèªã(2019/8/12) ï¼ï¼ä»£ã«ãªã£ã¦ãããç§ã®è©ã®èª¿åããããªããé«ãæã®ãã®ãåããã¨è ãä¸ããã¨ãããªããªã¨çã¿ãããäºåè©ãã¨ã¯ããèããããååè©ããâ¦[ç¶ããèªã] ï¼ï¼æ³ã§çªç¶ãéææ£è ã«ãä»äºãçµå©ãç¡çãªã®ãï¼[æ£è ãçãã](2019/8/10)  ç¡ç æç¡å¼å¸çãã¤ãã¬æ©ã¿ãç ããªãæ¼ééããããã[æ£è ãçãã](2019/8/12)  è¬åã®æã¿ã¯ï¼ãæ¡ã§ãããæ«æ女æ§ãå±ããæç´[ãã¥ã¼ã¹ã»ãã©ã¼ã«ã¹](2019/8/8)  é·å¼ãä½ã®ä¸èª¿ããã¤ç ããããå¹´ã®ãããã¨çãè¦ãã«[èãã¨ã¨ãã«](2019/8/7)  çè·å¸«ç®æãå¤å½äººãè½ã¡ã¦ããç¹å®æè½ãã¸ãæ¿åºæ¤è¨[ãã¥ã¼ã¹ã»ãã©ã¼ã«ã¹](2019/8/11) ãå°¼å´ã«éã空ããå ¬å®³ã¨éãåä¸ç´ãæ¾ãããç¹å¥è¡¨å½°[ãã¥ã¼ã¹ã»
æ°ç®¡æ¯ããããã®ãããåãæ¦ç°è¬åå·¥æ¥ã®æ¶çå¤ããã¼ã¼ã³ãï¼ä¸è¬åã»ã©ããã¿ã¼ã¼ï¼ã«å¹æããªãã¨ãããåé¡ã§ãå社ã¯ï¼ï¼æ¥ãæå¹æ§ãæ¤è¨¼ããå試é¨ã®å®æ½ã¯é£ããã¨ãã¦è²©å£²ãæã¡åããèªä¸»ååããã¨çºè¡¨ããã ï¼æã®åçå´åçå»è¬ååè©ä¾¡é¨ä¼ã§ãæ¿èªã®åãæ¶ãã審è°ãããè¦éãã ãã¼ã¼ã³ã¯ï¼ï¼ï¼ï¼å¹´ã«æ¿èªãããå»å¸«ã®å¦æ¹ãå¿ è¦ãªé£²ã¿è¬ãå社ãæ ¢æ§æ°ç®¡æ¯çã®æ£è ï¼ï¼ï¼äººã対象ã«å®æ½ãã試é¨ã§æå¹æ§ãèªããããªãã£ãã å社ã«ããã¨ããã¼ã¼ã³ã¯ç é¢ï¼ï¼ï¼ï¼ãæã診çæï¼ä¸ï¼ï¼ï¼ï¼ãæã調å¤è¬å±ï¼ä¸ï¼ï¼ï¼ï¼ãæã«åºè·ãã¦ãããå¹´é売ãä¸ãã¯ç´ï¼ï¼ååï¼ï¼ï¼ï¼ï¼å¹´åº¦æ±ºç®ãã¼ã¹ï¼ã
ååçºé µããªã³ã¯21æ¥ãè±è£½è¬ä¼ç¤¾ã®ããã¹ãã©ã«ã³ã»ã°ã«ã¼ãï¼ã¹ã³ããã©ã³ãï¼ã6æã«è²·åããã¨çºè¡¨ãããè²·åéé¡ã¯ç´2.92åãã³ãï¼ç´394ååï¼ãååããªã³ã¯ããã®å ç«æ©è½ãå¿ç¨ããæä½å»è¬åã®éçºã«åãå ¥ãã¦ãããããã¹ãã©ã«ã³ãæã¤æ¬§ç±³ã®è²©å£²ç¶²ã§ããããå»è¬åã売ãåºããæµ·å¤å±éãå éãããè²·åã
è¡æ¶²ä¸ã®ç¹æ®ãªéºä¼åã®éããæªæ§ãªã³ãè «ã®ç ç¶ã®å¤åãäºæ¸¬ããæ¹æ³ãæ¥æ¬ã®ç 究ã°ã«ã¼ããéçºãããæããå¤ãå¹ãçç¶ãæ¶ãã¦ç»åã§ããããè¦ããªããªã£ãææã«ä½¿ããæ£è ã«ã¨ã£ã¦ã¯å®æ²»ããã®ããåçºãããã®ããä¸å®ã«ããããææã ããã®æ¹æ³ã§ç確ã«åçºã®å¯è½æ§ã®æç¡ãå¤æã§ãããã¨ã«ãªãã°ãæ²»çæ¹éãç確ã«ç«ã¦ãããããã§é¢ä¿è ã®æå¾ ã¯å¤§ããã è¡ä¸ã®ãã¤ã¯ãRNAãè¨ãã ã éçºããã®ã¯æ±äº¬å»ç§å¤§å¦ååç çå¦ã®é»ç°é 彦ï¼ããã ã»ã¾ãã²ãï¼ææãè¡æ¶²å ç§ã®å¤§å±æ·ä¸é¦¬ï¼ãããããã»ããã¾ï¼ææãã®ã°ã«ã¼ãã ã«ã®ãæ¡ãã®ã¯ãããã¤ã¯ãRNAãï¼ãã¤ã¯ãã»ã¢ã¼ã«ã»ã¨ãã»ã¨ã¼ï¼ã¨å¼ã°ããç´°èå ã«ããå°ããªæçã®éºä¼åãæ£å¸¸ãªç´°èãããç´°èããè¡æ¶²ã®ä¸ã«åºã¦ãããã®ã ãã§ç´300種é¡ãç¥ããã¦ããããæ¬æ ¼çãªç 究ã¯æ°å¹´åã«å§ã¾ã£ãã°ããã ãæ¬æ¥ã®éºä¼åDNAï¼ãã£ã¼ã»ã¨ãã»ã¨ã¼ï¼ã®é·ãéã®ããä¸é¨ã®
æ¥æ¬çµæ¸æ°èã®é»åçãããã¸ãã¹ãã«é¢ããææ°ã®ãã¥ã¼ã¹ããå±ããã¾ãã
ãã¡ãªãã·ã¼ã®ã¬ã¡ãã£ã¯å®è³ªçã«ç ç³çã¨ä¸ç·ã§ãè¬ççãªå¹æã¯ä½ããªããã«ãé¢ããããã¨ããããã ããããã診çã§ã¬ã¡ãã£ã使ããããçµæ§ä¾¿å©ã ããããããã§ã使ãããã¯ããããã¨ãã°ã è¬ã«æµæã®ãã人㫠ãã¯ã¯ãã³ã¯å«ããã¹ããã¤ãã£ã¦å¯ä½ç¨ãé ·ããã§ãããï¼ããªã©ã¨ãå¯ä½ç¨ãé度ã«æãã¦ãå»å¦çã«å¿ è¦ãªè¬ã®ä½¿ç¨ãå«ãã人ããããè¬ã使ããªããããè¬ï¼ç ç³çã®ã»ããã¾ããã¨ããå ´åã«ã¯ããè¬ã®æ害æ§ãæã¡æ¶ãã¬ã¡ãã£ã¼ããåæã«æã£ã¦ããããã¨ã§ãè¬ã®ä½¿ç¨ã«ç´å¾ãå¾ããããªããå®éã«ã¯ãè¬ã®æ害æ§ãæã¡æ¶ããã®ã§ã¯ãªãããè¬ã«å¯¾ããä¸å®æãæã¡æ¶ãããã¨ãæå¾ ãã¦ä½¿ãã è¬ãä¸è¦ã®äººã« ä¸æ¹ã§ãåãªã風éªã«å¯¾ãã¦ããç·åæåè¬ã¨è§£ç±è¬ã¨å³æ¢ãã¨æçç©è³ªã¨èè¬ãå¦æ¹ãã¦ãã ããããªã©ã¨ãå»å¦çã«ã¯ä¸è¦ãªã®ã«ãããã¨è¬ãå¸æããæ£è ããããããããããæ£è ããã«ã¯ããèªç¶æ²»çåãå¼ãåºãã¬
ãããã¯ã»ã³ããã¬ï¼Dominique Cottrezï¼è¢«åããã§ã¼ã¹ããã¯ï¼Facebookï¼ä¸ã«æ²è¼ãã¦ããé¡åçã(c)AFP/FACEBOOK ã8æ3æ¥ AFPããã©ã³ã¹ã®æã§æ°çå ã®éºä½8ä½ãè¦ã¤ãã£ãäºä»¶ã§ã殺害容çãããããã¦ããæ¯è¦ªï¼45ï¼ã®å¼è·å£«ã主張ãã注ç®ããã¦ããã®ãï½¢å¦å¨ å¦èªï½£ã¨å¼ã°ããç²¾ç¥çç¶ã ã ãã®ï½¢å¦å¨ å¦èªï½£ã¯ããã©ã³ã¹ã§ã¯å¹¼å 殺害äºä»¶ã®éã«å¼è·å´ãã責任è½åãåããªããã¨ã主張ããããã«ãããã¾ã§ã«ãæã¡åºããã¦ãããããã¯æ£å½ã ã¨ããã³ãï¼Nantesï¼ã«ããç£å©¦äººç§ç é¢ã®ç²¾ç¥ç§å»ãã½ãã£ã¼ã»ããªãããã¹ï¼Sophie Marinopoulosï¼å»å¸«ã¯èªããï½¢ããããç¥ã£ã¦ããéããåã©ãã殺ãããã«å¦å¨ ãããã¨ãã女æ§ã¯ãã¾ãããããã¯ç²¾ç¥ççç¶ãªã®ã§ãï½£ â 3種é¡ã®å¦å¨ å¦èª ï½¢å¦å¨ å¦èªï½£ãå°é家ã¯3種é¡ã«åé¡ãã¦ããã第1ã®ç¨®é¡ã¯ï½¢åºæ±æ§å¦èªï½£ã¨
京é½å¤§å¦ç é¢ã§æ¨å¹´ï¼ï¼æãå ¥é¢æ£è ãé«æ¿åº¦ã¤ã³ã¹ãªã³ã«ããä½è¡ç³çºä½ã§æèä¸æã«ãªã£ãäºä»¶ã«é¢é£ãã京é½åºè¦ææ»ï¼èª²ã¨å·ç«¯ç½²ã¯ï¼æ¥ãæ£è ã®çè·è¨é²ã«èå½ã®è¡ç³å¤ãè¨è¼ããå ¬é»ç£çè¨é²ä¸æ£ä½åºã¨åä¾ç¨ã®å®¹çã§ãæ£è ã®æ å½çè·å¸«ã®æ¨åç¾ç©å®¹çè ï¼ï¼ï¼ï¼ï¼äº¬é½å¸å·¦äº¬åºåç°ä¸é¿éçºï¼ãé®æãããåºè¦ã¯ã¤ã³ã¹ãªã³ã人çºçã«æä¸ãããã¨ã¿ã¦æ®ºäººæªéãå·å®³å®¹çãè¦éã«å ¥ãã¦ææ»ãã¦ãããæ¨å容çè ã®é¢ä¸ã調ã¹ãã åºè¦ã®çºè¡¨ã§ã¯ãæ¨å容çè ã¯ãééãããã¾ãããã¨å®¹çãèªãã¦ãããä»å¾ãåæ©ã追åããã é®æ容çã¯ãæ¨å¹´ï¼ï¼æï¼ï¼ï½ï¼ï¼æ¥ã循ç°å¨å ç§ã«å ¥é¢ä¸ã®å¥³æ§æ£è ï¼ï¼ï¼ï¼ã®ç ç¶ãä½è¡ç³ã«ããæ¥å¤ããéã容ä½ã®å®å®ãè£ ããããå ¥å端æ«ã§æ°åãçè·è¨é²ã«æ£å¸¸ãªè¡ç³å¤ãå ¥åããã¨ããããåºè¦ã«ããã¨ãçè·è¨é²ã¯é¢å ã®ãã½ã³ã³ã§ç®¡çãããçè·å¸«ãåã ã®ï¼©ï¼¤ããã¹ã¯ã¼ãã使ãæ å½æ£è ã®ç¶æ ãå ¥åããã 京大ç
ã©ã³ãã³ã°
é害
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}